I own POZN, lots of it in fact, have had it for many years. It has done mostly nothing, except for a spike when they announced a special div last Dec - the FDA has screwed them multiple times on the PA franchise, nearly as bad as they screwed with AMRN. Per Vimovo and Horizon and AZN, the latter had little interest in selling it, no promotion, no push, so no sales - too tiny of a market for them, a drop in the bucket. Horizon is a little company, it's financial success is much more dependent on great Vimovo sales, ergo the bigger push it's doing. Hopefully Kowa will be our Horizon! If they are making a difference, it should show up within the next month or two I'd think.
Market Data 
Markets 
AI
